Clinical Trials
36 trialsLSFG-SKIN, Laser Speckle Flowgraphy
University of Iowa
Stanford Accelerated Recovery Trial (START)
Stanford University
STARRT
Merit Medical Systems, Inc.
CORAL
Tris Pharma, Inc.
Fentanyl for Breakthrough Pain in the Emergency Department
M.D. Anderson Cancer Center
Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer
Pfizer
Non-cancer Pain and Cognitive Impairment: A Disabling Relationship
University of Chicago
Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer
M.D. Anderson Cancer Center
Quell Opioid Reduction and Pain Relief in Patients With Cancer
Scripps Translational Science Institute
Tapentadol in Chronic Malignant Tumour Related Pain
Grünenthal GmbH
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Hospice of Henderson County, Inc.
Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN
Stanford University
Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases
Alliance for Clinical Trials in Oncology
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain
UNC Lineberger Comprehensive Cancer Center
COMET-2
Exelixis
Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer
Radiation Therapy Oncology Group
Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer
OHSU Knight Cancer Institute
A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction
Yale University
A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients
University of Miami
Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients
University of Michigan Rogel Cancer Center
Role of Methadone As Co-Opioid Analgesic
M.D. Anderson Cancer Center
Methadone Versus Morphine for Cancer-Related Pain
Mayo Clinic
Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer
Mayo Clinic
IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
Yale University
Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer
M.D. Anderson Cancer Center
Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sleep and Endometrial Cancer
University of Pittsburgh
D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain
Northwestern University
Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain
Janssen Pharmaceutica
A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain
Johnson & Johnson Taiwan Ltd
Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain
M.D. Anderson Cancer Center